10:37 AM EST - Profound Medical Corp. : Today announced preliminary unaudited revenues for the fourth quarter and full year 2024. Profound anticipates total revenue for the fourth quarter of 2024 to be in the approximate range of $4.1 million to $4.2 million, representing year-over-year growth of between 105% and 110%, and sequential quarter-over-quarter growth of between 45% and 48%. Full year 2024 total revenue is expected to be approximately $11.1 million to $11.2 million, compared to approximately $7.2 million in the prior year period. These figures are preliminary and unaudited, and actual revenues may differ. Profound Medical Corp.
shares T.PRN are trading down $0.10 at $10.89.
